Skip to main content
. Author manuscript; available in PMC: 2016 Oct 10.
Published in final edited form as: Eur Urol. 2015 May 16;68(4):570–577. doi: 10.1016/j.eururo.2015.04.032

Fig. 1.

Fig. 1

Fig. 1

Fig. 1

Kaplan-Meier estimates of (A) overall survival, (B) time to opiate use for cancer-related pain, and (C) time to deterioration in Eastern Cooperative Oncology Group (ECOG) performance status score by ≥1 point. AA = abiraterone acetate; BTT = bone-targeted therapy; CI = confidence interval; NE = not estimable; P = prednisone.